Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

Sally Taylor; Selina Tsim; Neal Navani; David Baldwin; Ian Woolhouse; John Edwards; Seamus Grundy; Jonathan Robson; Sarah Rhodes; Nathan Burnside; Fiona Blackhall; Corinne Faivre-Finn; Janelle Yorke; Matthew Evison

doi:10.1016/s0169-5002(22)00198-2

Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

Sally Taylor, Selina Tsim, Neal Navani, David Baldwin, Ian Woolhouse, John Edwards, Seamus Grundy, Jonathan Robson, Sarah Rhodes, Nathan Burnside, Fiona Blackhall, Corinne Faivre-Finn, Janelle Yorke, Matthew Evison

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S69
Journal	Lung Cancer
Volume	165
DOIs	https://doi.org/10.1016/s0169-5002(22)00198-2
Publication status	Published - Mar 2022

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0169-5002(22)00198-2

Cite this

Taylor, S., Tsim, S., Navani, N., Baldwin, D., Woolhouse, I., Edwards, J., Grundy, S., Robson, J., Rhodes, S., Burnside, N., Blackhall, F., Faivre-Finn, C., Yorke, J., & Evison, M. (2022). Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). Lung Cancer, 165, S69. https://doi.org/10.1016/s0169-5002(22)00198-2

@article{ff80f9571cf944e69fa9e8052c03ffec,

title = "Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)",

author = "Sally Taylor and Selina Tsim and Neal Navani and David Baldwin and Ian Woolhouse and John Edwards and Seamus Grundy and Jonathan Robson and Sarah Rhodes and Nathan Burnside and Fiona Blackhall and Corinne Faivre-Finn and Janelle Yorke and Matthew Evison",

year = "2022",

month = mar,

doi = "10.1016/s0169-5002(22)00198-2",

language = "English",

volume = "165",

pages = "S69",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier BV",

}

Taylor, S, Tsim, S, Navani, N, Baldwin, D, Woolhouse, I, Edwards, J, Grundy, S, Robson, J, Rhodes, S, Burnside, N, Blackhall, F , Faivre-Finn, C , Yorke, J & Evison, M 2022, 'Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)', Lung Cancer, vol. 165, pp. S69. https://doi.org/10.1016/s0169-5002(22)00198-2

Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). / Taylor, Sally; Tsim, Selina; Navani, Neal et al.
In: Lung Cancer, Vol. 165, 03.2022, p. S69.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

AU - Taylor, Sally

AU - Tsim, Selina

AU - Navani, Neal

AU - Baldwin, David

AU - Woolhouse, Ian

AU - Edwards, John

AU - Grundy, Seamus

AU - Robson, Jonathan

AU - Rhodes, Sarah

AU - Burnside, Nathan

AU - Blackhall, Fiona

AU - Faivre-Finn, Corinne

AU - Yorke, Janelle

AU - Evison, Matthew

PY - 2022/3

Y1 - 2022/3

UR - https://www.mendeley.com/catalogue/b8890ae1-fb74-3b68-9cfd-b873bb1f8fdc/

U2 - 10.1016/s0169-5002(22)00198-2

DO - 10.1016/s0169-5002(22)00198-2

M3 - Article

SN - 0169-5002

VL - 165

SP - S69

JO - Lung Cancer

JF - Lung Cancer

ER -

Taylor S, Tsim S, Navani N, Baldwin D, Woolhouse I, Edwards J et al. Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). Lung Cancer. 2022 Mar;165:S69. doi: 10.1016/s0169-5002(22)00198-2

Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Other files and links

Cite this